Section Arrow
Quote
ISPC.NASDAQ
- iSpecimen Inc.
Quotes are at least 15-min delayed:2026/06/09 17:06 EDT
After Hours
Last
 2.96
+0.04 (+1.37%)
Bid
2.96
Ask
3
High 3.0297 
Low 2.92 
Volume 6.36K 
Regular Hours (Closed)
Last
 2.92
-0.03 (-1.02%)
Day High 
3.09 
Prev. Close
2.95 
1-M High
5.5 
Volume 
193.88K 
Bid
2.96
Ask
3
Day Low
2.75 
Open
2.95 
1-M Low
2.9 
Market Cap 
4.24M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.18 
20-SMA 3.59 
50-SMA 4.68 
52-W High 127.2 
52-W Low 2.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-329.05/--
Enterprise Value
4.45M
Balance Sheet
Book Value Per Share
0.57
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.93M
Operating Revenue Per Share
7.18
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NOTVInotiv0.095-0.0161-14.49%-- 
After Hours 0.0902 -0.0048 -5.05%
DHRDanaher Corp188.41+4.88+2.66%36.78PE
After Hours 188.34 -0.07 -0.04%
PSNLPersonalis9.75-0.29-2.89%-- 
After Hours 9.75 0 0.00%
SHCSotera Health Company16.53+0.67+4.22%40.32PE
After Hours 16.53 0 0.00%
TMOThermo Fisher Scientific494.07+24.44+5.20%26.47PE
After Hours 481.5 -12.57 -2.54%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from theAmericas. The Company has one reportable segment: biospecimens.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.